IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR-INFILTRATING T-LYMPHOCYTE SUBPOPULATIONS OF THE WARTHIN-LIKE VARIANT OF PAPILLARY THYROID CANCER
- 作者: Bogolyubova A.V.1,2, Abrosimov A.Y.3,4, Selivanova L.S.5, Dvinskikh N.Y.6, Kuprash D.V.1, Belousov P.V.1,4
-
隶属关系:
- Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences
- Educational Fund “Talent and Success”, Educational center “Sirius”
- National Medical Research Center for Endocrinology
- National University of Science & Technology «MISIS»
- Department of Basic Pathology, National Medical Research Center for Endocrinology
- A. Tsyb Medical Radiological Research Center, Ministry of Health of Russian Federation
- 期: 卷 22, 编号 1 (2019)
- 页面: 24-30
- 栏目: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/1028-7221/article/view/119332
- DOI: https://doi.org/10.31857/S102872210005017-3
- ID: 119332
如何引用文章
全文:
详细
Tumor-infiltrating immune cells, in particular T-lymphocytes, can both stimulate and inhibit the tumor growth. Warthin-like variant of papillary thyroid cancer is a unique tumor characterized by an abnormally abundant immune infi ltration. We performed the analysis of the composition of T-cell subpopulations in the contexture of this type of cancer.
作者简介
A. Bogolyubova
Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences;Educational Fund “Talent and Success”, Educational center “Sirius”
编辑信件的主要联系方式.
Email: apollinariya.bogolyubova@gmail.com
junior staff scientist Laboratory of intracellular signaling in health and disease, 119991, Moscow, Vavilova str., 32;
staff scientist, Sochi
俄罗斯联邦A. Abrosimov
National Medical Research Center for Endocrinology;National University of Science & Technology «MISIS»
Email: fake@neicon.ru
PhD, head of the department Department of Basic Pathology;
Laboratory «Physical methods, acousto-optical and laser devices for diagnosis and therapy of oncological diseases»,
Moscow
俄罗斯联邦L. Selivanova
Department of Basic Pathology, National Medical Research Center for Endocrinology
Email: fake@neicon.ru
PhD, senior staff scientist Department of Basic Pathology,
Moscow
俄罗斯联邦N. Dvinskikh
A. Tsyb Medical Radiological Research Center, Ministry of Healthof Russian Federation
Email: fake@neicon.ru
PhD, head of the Department of Pathology, Obninsk 俄罗斯联邦
D. Kuprash
Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences
Email: fake@neicon.ru
PhD, head of the Laboratory of intracellular signaling in health and disease,
Moscow
俄罗斯联邦P. Belousov
Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences;National University of Science & Technology «MISIS»
Email: fake@neicon.ru
junior staff scientist Laboratory of intracellular signaling in health and disease;
Laboratory «Physical methods, acousto-optical and laser devices for diagnosis and therapy of oncological diseases»,
Moscow
俄罗斯联邦参考
- Fridman W.-H., Dieu-Nosjean M.-C., Pagès F., Cremer I., Damotte D., Sautès-Fridman C., Galon J. The immune microenvironment of human tumors: general significance and clinical impact. Cancer Microenviron. 2013. 6 (2), 117–122.
- Fridman W. H., Pagès F., Sautès-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 2012, 12 (4), 298–306.
- Hadrup S., Donia M., Thor Straten P. Eff ector CD4 and CD8 T cells and their role in the tumor microenvironment. Cancer Microenviron. 2013, 6 (2), 123–133.
- Gu-Trantien C., Loi S., Garaud S., Equeter C., Libin M., de Wind A., Ravoet M., Le Buanec H., Sibille C., Manfouo-Foutsop G., Veys I., Haibe-Kains B., Singhal S. K., Michiels S., Rothé F., Salgado R., Duvillier H., Ignatiadis M., Desmedt C., Bron D., Larsimont D., Piccart M., Sotiriou C., Willard-Gallo K., Perou C., Sorlie T., Sotiriou C., Pusztai L., Sotiriou C., Ascierto M., Teschendorff A., Miremadi A., Pinder S., Ellis I., Caldas C., Alexe G., Desmedt C., Schmidt M., Rody A., Yau C., Esserman L., Moore D., Waldman F., Sninsky J., Benz C., Ascierto M., Rody A., Rahir G., Moser M., Mahmoud S., Mahmoud S., Lee A., Ellis I., Green A., Bos R., Marquardt K., Cheung J., Sherman L., Bos R., Sherman L., Ruff ell B., DeNardo D., Aff ara N., Coussens L., Zamarron B., Chen W., Gobert M., Wilke C., Ye J., Livergood R., Peng G., deLeeuw R., Kost S., Kakal J., Nelson B., Chaisemartin L. de, Dieu-Nosjean M., Coppola D., Vinuesa C., Cyster J., Ruff ell B., Au A., Rugo H., Esserman L., Hwang E., Coussens L., Chtanova T., Miyara M., Lee M., Hanspers K., Barker C., Korn A., McCune J., Ravoet M., Zaunders J., Baniyash M., Fazilleau N., Mark L., McHeyzer-Williams L., McHeyzer-Williams M., Balkwill F., Razis E., Panse J., Link A., Crotty S., Viegas M., Crotty S., Ignatiadis M., Grange C., Hayden M., Ghosh S., Kim T., Chang M., Yu K., Kwon H., Norman D., Vig E., Goebl M., Harrington M., Macian F., Lopez-Rodriguez C., Rao A., Xiao G., Deng A., Liu H., Ge G., Liu X., Ghebeh H., Good-Jacobson K., Szumilas C., Chen L., Sharpe A., Tomayko M., Shlomchik M., Mihalj M., Kellermayer Z., Balogh P., Inozume T., O’Shea J., Paul W., Galon J., Yoon H., Orrock J., Foster N., Sargent D., Smyrk T., Sinicrope F., Shankaran V., Curtis N., Primrose J., Thomas G., Mirnezami A., Ottensmeier C., Haabeth O., Braumuller H., Ji Y., Zhang W., Kryczek I., Curiel T., Ladoire S., Kim M., Watanabe M., Oda J., Amarante M., Voltarelli J. C., Bates G., West N., Breitfeld D., Schaerli P., Willimann K., Lang A., Lipp M., Loetscher P., Moser B., McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L., Ramiscal R., Vinuesa C., Nelson B., Lohr M., Mahmoud S., Lee A., Paish E., Macmillan R., Ellis I., Green A., Nielsen J., Ladanyi A., Maletzki C., Jahnke A., Ostwald C., Klar E., Prall F., Linnebacher M., Coronella J., CoronellaWood J., Hersh E., Bianchini G., Foo S., Phipps S., Martinet L., Muller G., Hopken U., Lipp M., Wang C., Hillsamer P., Kim C., Denkert C., Haibe-Kains B. CD4+ follicular helper T cell infi ltration predicts breast cancer survival. J. Clin. Invest. 2013, 123 (7), 2873–2892.
- Bronkhorst I. H. G., Vu T. H. K., Jordanova E. S., Luyten G. P. M., Burg S. H. van der, Jager M. J. Diff erent Subsets of Tumor-Infiltrating Lymphocytes Correlate with Macrophage Infl ux and Monosomy 3 in Uveal Melanoma. Investig. Opthalmology Vis. Sci. 2012, 53 (9), 5370.
- Chaudhary B., Elkord E. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines 2016, 4 (3), 28.
- Sakuishi K., Apetoh L., Sullivan J. M., Blazar B. R., Kuchroo V. K., Anderson A. C. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 2010, 207 (10), 2187–2194.
- Park H.J., Kusnadi A., Lee E.-J., Kim W. W., Cho B. C., Lee I. J., Seong J., Ha S.-J. Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cell. Immunol. 2012, 278 (1–2), 76–83.
- Schmidt A., Oberle N., Krammer P. H. Molecular mechanisms of treg-mediated T cell suppression. Front. Immunol. 2012, 3, 51.
- Dieu-Nosjean M.-C., Antoine M., Danel C., Heudes D., Wislez M., Poulot V., Rabbe N., Laurans L., Tartour E., de Chaisemartin L., Lebecque S., Fridman W.-H., Cadranel J. Long-term survival for patients with non-smallcell lung cancer with intratumoral lymphoid structures. J. Clin. Oncol. 2008, 26 (27), 4410–4417.
- Dieu-Nosjean M.-C., Giraldo N. A., Kaplon H., Germain C., Fridman W. H., Sautès-Fridman C. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol. Rev. 2016, 271 (1), 260–275.
- Castan J., Tenner-Racz K., Racz P., Fleischer B., Bröker B. M. Accumulation of CTLA-4 expressing T lymphocytes in the germinal centres of human lymphoid tissues. Immunology 1997, 90 (2), 265–271.
- Wang C. J., Heuts F., Ovcinnikovs V., Wardzinski L., Bowers C., Schmidt E. M., Kogimtzis A., Kenefeck R., Sansom D. M., Walker L. S. K. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement. Proc. Natl. Acad. Sci. U. S. A. 2015, 112 (2), 524–529.
- Sage P. T., Paterson A. M., Lovitch S. B., Sharpe A. H. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity 2014, 41 (6), 1026–1039.
- Sage P. T., Francisco L. M., Carman C. V, Sharpe A. H. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat. Immunol. 2013, 14 (2), 152–161.
- Solinas C., Garaud S., De Silva P., Boisson A., Van den Eynden G., de Wind A., Risso P., Rodrigues Vitória J., Richard F., Migliori E., Noël G., Duvillier H., Craciun L., Veys I., Awada A., Detours V., Larsimont D., Piccart-Gebhart M., Willard-Gallo K. Immune Checkpoint Molecules on Tumor-Infi ltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Front. Immunol. 2017, 8, 1412.
- Apel R. L., Asa S. L., LiVolsi V. A. Papillary Hürthle cell carcinoma with lymphocytic stroma. «Warthin-like tumor» of the thyroid. Am. J. Surg. Pathol. 1995, 19 (7), 810–814.
- D’Antonio A., De Chiara A., Santoro M., Chiappetta G., Losito N. S. Warthin-like tumour of the thyroid gland: RET/PTC expression indicates it is a variant of papillary carcinoma. Histopathology 2000, 36 (6), 493–498.
- Urano M., Abe M., Kuroda M., Mizoguchi Y., Horibe Y., Kasahara M., Tanaka K., Sudo K., Hirasawa Y. Warthin-like tumor variant of papillary thyroid carcinoma: case report and literature review. Pathol. Int. 2001, 51 (9), 707–712.
- Vera-Sempere F. J., Prieto M., Camañas A. Warthinlike Tumor of the Thyroid: A Papillary Carcinoma with Mitochondrion-rich Cells and Abundant Lymphoid Stroma. A Case Report. Pathol. – Res. Pract. 1998, 194 (5), 341–347.
- Lam K. Y., Lo C. Y., Wei W. I. Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior. Endocr. Pathol. 2005, 16 (1), 83–89.
- Amico P., Lanzafame S., Li Destri G., Greco P., Caltabiano R., Vecchio G. M., Magro G. Warthin tumor-like papillary thyroid carcinoma with a minor dediff erentiated component: report of a case with clinicopathologic considerations. Case Rep. Med. 2010, 495281.
- Shi J., Hou S., Fang Q., Liu X., Liu X., Qi H. PD-1 Controls Follicular T Helper Cell Positioning and Function. Immunity 2018, 49 (2), 264–274.e4.
- Joshi N. S., Akama-Garren E. H., Lu Y., Lee D.-Y., Chang G. P., Li A., DuPage M., Tammela T., Kerper N. R., Farago A. F., Robbins R., Crowley D. M., Bronson R. T., Jacks T. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. Immunity 2015, 43 (3), 579–590.
补充文件
